DAWN TOPE: Open Payments
NPI 1366644320 · ROLLA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $14 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 3 | $61 |
| Lilly USA, LLC | 2 | $46 |
| PFIZER INC. | 2 | $39 |
| Dexcom, Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
| Organon LLC | 1 | $11 |
Products named: BRIXADI, MOUNJARO, PREVNAR 20, Dexcom G6 Transmitter, CAPLYTA, REXULTI, SPRAVATO, NEXPLANON.
Industry payments across MO — which companies pay providers there.
